MAPK3 and cancer: Although MEL was reported to be cytostatic for cancer cells through ERK1/2 signaling [36,65,66], the stimulation of MEL on the MEK/ERK1/2 pathway was also shown to mediate protective signaling transduction [67] and cell proliferation [68].